Education
About Us
Working with TipRanks
Follow Us
Janux Therapeutics, Inc. (JANX)
NASDAQ:JANX
JANX Analyst Ratings
Strong Buy
14 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
JANX Stock 12 Month Forecast
Average Price Target
$52.58
▲(298.03% Upside)
| Highest Price Target$150.00 | Average Price Target$52.58 | Lowest Price Target$12.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
$45
Buy
240.65%
Upside
Reiterated
02/18/26
William Blair
Buy
―
Reiterated
02/17/26
JonesTrading
$50
Buy
278.50%
Upside
Assigned
01/23/26
BTIG
$100
Buy
657.00%
Upside
Reiterated
01/22/26
Clear Street
$32→$12
Hold
-9.16%
Downside
Downgraded
01/20/26
Piper Sandler
$42→$30
Buy
127.10%
Upside
Reiterated
01/16/26
Bank of America Securities
$49→$35
Buy
164.95%
Upside
Reiterated
01/06/26
TD Cowen
Buy
―
Reiterated
12/24/25
Truist Financial
Buy
―
Reiterated
12/24/25
Barclays
$48→$29
Buy
119.53%
Upside
Reiterated
12/17/25
LifeSci Capital
$100→$60
Buy
354.20%
Upside
Reiterated
12/06/25
Cantor Fitzgerald
$200→$150
Buy
1035.50%
Upside
Reiterated
12/02/25
Stifel Nicolaus
$46→$38
Buy
187.66%
Upside
Reiterated
12/02/25
Evercore ISI
$25
Buy
89.25%
Upside
Reiterated
12/02/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
$45
Buy
240.65%
Upside
Reiterated
02/18/26
William Blair
Buy
―
Reiterated
02/17/26
JonesTrading
$50
Buy
278.50%
Upside
Assigned
01/23/26
BTIG
$100
Buy
657.00%
Upside
Reiterated
01/22/26
Clear Street
$32→$12
Hold
-9.16%
Downside
Downgraded
01/20/26
Piper Sandler
$42→$30
Buy
127.10%
Upside
Reiterated
01/16/26
Bank of America Securities
$49→$35
Buy
164.95%
Upside
Reiterated
01/06/26
TD Cowen
Buy
―
Reiterated
12/24/25
Truist Financial
Buy
―
Reiterated
12/24/25
Barclays
$48→$29
Buy
119.53%
Upside
Reiterated
12/17/25
LifeSci Capital
$100→$60
Buy
354.20%
Upside
Reiterated
12/06/25
Cantor Fitzgerald
$200→$150
Buy
1035.50%
Upside
Reiterated
12/02/25
Stifel Nicolaus
$46→$38
Buy
187.66%
Upside
Reiterated
12/02/25
Evercore ISI
$25
Buy
89.25%
Upside
Reiterated
12/02/25
Best Analysts Covering Janux Therapeutics Inc
3 Months
xxx
Success Rate
5/14 ratings generated profit
Average Return
-7.46%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 35.71% of your transactions generating a profit, with an average return of -7.46% per trade.
1 Year
Success Rate
2/9 ratings generated profit
Average Return
+7.09%
reiterated a buy rating 10 months ago
Copying Robert Driscoll's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of +7.09% per trade.
2 Years
xxx
Success Rate
2/9 ratings generated profit
Average Return
-30.72%
reiterated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 22.22% of your transactions generating a profit, with an average return of -30.72% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
JANX Analyst Recommendation Trends
Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
18
20
24
26
16
Buy
4
4
10
9
8
Hold
71
73
54
32
19
Sell
1
1
1
0
0
Strong Sell
0
0
0
0
0
total
94
98
89
67
43
Each month's total comprises the sum of three months' worth of ratings.
JANX Financial Forecast
JANX Stock Forecast FAQ
What is JANX’s average 12-month price target, according to analysts?
Based on analyst ratings, Janux Therapeutics, Inc.’s 12-month average price target is 52.58.
What is JANX’s upside potential, based on the analysts’ average price target?
Janux Therapeutics, Inc. has 298.03% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is JANX a Buy, Sell or Hold?
Janux Therapeutics, Inc. has a consensus rating of Strong Buy which is based on 14 buy ratings, 1 hold ratings and 0 sell ratings.
What is Janux Therapeutics, Inc.’s price target?
The average price target for Janux Therapeutics, Inc. is 52.58. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $150.00 ,the lowest forecast is $12.00. The average price target represents 298.03% Increase from the current price of $13.21.
The highest analyst price target is $150.00 ,the lowest forecast is $12.00. The average price target represents 298.03% Increase from the current price of $13.21.
What do analysts say about Janux Therapeutics, Inc.?
Janux Therapeutics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of JANX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.